FDCDDQ
DYN icon

Federation des caisses Desjardins du Quebec’s Dyne Therapeutics DYN Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$190 – 2918
2025
Q2 		$190 Hold
20
– – ﹤0.01% 2634
2025
Q1 		$209 Hold
20
– – ﹤0.01% 2563
2024
Q4 		$471 Hold
20
– – ﹤0.01% 2390
2024
Q3 		$718 Buy
+20
New +$796 ﹤0.01% 2353

Other funds holding DYN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's DYN Position: Q3 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Dyne Therapeutics (DYN) in Q3 2025, closing a stake of 20 shares — an estimated $190 sold.

Federation des caisses Desjardins du Quebec first reported a position in DYN in Q3 2024 and held it in 4 quarters. The position peaked at $718 in Q3 2024. 207 funds tracked by Wall St. Rank hold DYN as of Q3 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Dyne Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 20 Dyne Therapeutics shares in Q3 2025, an estimated $190.
  • Federation des caisses Desjardins du Quebec first reported a position in Dyne Therapeutics in Q3 2024 and held it in 4 quarters.
  • Federation des caisses Desjardins du Quebec's Dyne Therapeutics position peaked at $718 in Q3 2024.
  • 207 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2025, filed 14 Nov 2025.